Wednesday
October 18
- Poster Session 3:00 PM – 4:00 PM (6 Posters)
- Oral Presentations 12:00 PM – 12:15 PM
Rachid Karam, MD, PhD, Associate Director, ATG Lab Ambry Genetics
Ambry’s ATG lab was launched in 2016 with the goal of reducing the overall number of uncertain and uninformative results on clinical molecular testing through follow-up functional studies. Functional studies performed in the ATG lab include targeted RNA studies for gross duplications and splicing variants of unknown significance, as well as whole transcriptome sequencing (RNA-Seq) for patients with a clear clinical presentation but for whom DNA molecular testing failed to detect an explanatory alteration(s).